FDA Authorizes Moderna's COVID-19 Vaccine
Summary from the AllSides News Team
Featured Coverage of this Story
From the Right
FDA Approves Moderna's Coronavirus VaccineA week after the FDA approved the Pfizer/BioNTech coronavirus vaccine for emergency use, the agency has granted the same approval for Moderna's vaccine. In clinical trials, Moderna's candidate was over 94 percent effective.
On Thursday night, the Vaccines and Related Biological Products Advisory Committee voted 20-0 to recommend the vaccine be made available.
"The evidence that has been studied in great detail on this vaccine highly outweighs any of the issues we’ve seen," said Dr. Hayley Gans of Stanford University Medical Center.
HHS Secretary Alex Azar said Wednesday that the...
From the Left
FDA grants emergency authorization to Moderna's Covid-19 vaccineThe Food and Drug Administration authorized Moderna's Covid-19 vaccine for emergency use Friday, adding a second vaccine to the country's arsenal to fight the pandemic.
The United States is the first country to greenlight use of Moderna's vaccine, which was developed in part with the National Institutes of Health.
The news was met with optimism. "I've never been more hopeful that we will eventually turn the corner on this pandemic," said Dr. Richard Besser, former acting director of the Centers for Disease Control and Prevention and current president of the...
From the Center
U.S. FDA authorizes Moderna's COVID-19 vaccine for emergency useModerna Inc’s coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 307,000 lives lost.
The FDA announced the authorization the day after the agency’s panel of outside experts endorsed its use. Moderna said it intended to apply for full U.S. license in 2021.
The decision marks the first regulatory authorization in the world for Moderna’s vaccine and validation of its messenger RNA technology. It came less...
AllSides Picks
March 28th, 2024
March 28th, 2024
March 28th, 2024